We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+0.36%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.2B
AUM Growth
+$366M
Cap. Flow
+$107M
Cap. Flow %
0.7%
Top 10 Hldgs %
31.7%
Holding
1,371
New
97
Increased
870
Reduced
195
Closed
30

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$266M
2
SUI icon
Sun Communities
SUI
+$169M
3
EXR icon
Extra Space Storage
EXR
+$143M
4
AMT icon
American Tower
AMT
+$103M
5
KRC icon
Kilroy Realty
KRC
+$102M

Sector Composition

Rank Sector Weight
1 Real Estate 55.88%
2 Technology 9.18%
3 Communication Services 4.61%
4 Consumer Discretionary 4.25%
5 Financials 3.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KPTI icon
1251
Karyopharm Therapeutics
KPTI
$160M
$1K ﹤0.01%
9
KZR
1252
DELISTED
Kezar Life Sciences
KZR
$1K ﹤0.01%
9
MGTX icon
1253
MeiraGTx Holdings
MGTX
$1.09B
$1K ﹤0.01%
82
NGNE icon
1254
Neurogene
NGNE
$673M
$1K ﹤0.01%
4
PAHC icon
1255
Phibro Animal Health
PAHC
$1.5B
$1K ﹤0.01%
38
PBYI icon
1256
Puma Biotechnology
PBYI
$405M
$1K ﹤0.01%
87
RIGL icon
1257
Rigel Pharmaceuticals
RIGL
$739M
$1K ﹤0.01%
37
RLMD icon
1258
Relmada Therapeutics
RLMD
$555M
$1K ﹤0.01%
31
RNAC icon
1259
Cartesian Therapeutics
RNAC
$221M
$1K ﹤0.01%
7
SIGA icon
1260
SIGA Technologies
SIGA
$244M
$1K ﹤0.01%
172
SNAP icon
1261
PUT
Snap
SNAP
$8.16B
$1K ﹤0.01%
1,085
SYRE icon
1262
Spyre Therapeutics
SYRE
$8.57B
$1K ﹤0.01%
4
TBPH icon
1263
Theravance Biopharma
TBPH
$875M
$1K ﹤0.01%
120
TCRT icon
1264
Alaunos Therapeutics
TCRT
$4.69M
$1K ﹤0.01%
3
URGN icon
1265
UroGen Pharma
URGN
$2B
$1K ﹤0.01%
48
VSTM icon
1266
Verastem
VSTM
$542M
$1K ﹤0.01%
27
XBIT icon
1267
XBiotech
XBIT
$68.6M
$1K ﹤0.01%
64
QTTB icon
1268
Q32 Bio
QTTB
$454M
$1K ﹤0.01%
6
PSTX
1269
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1K ﹤0.01%
116
FUSN
1270
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$1K ﹤0.01%
78
MRNS
1271
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1K ﹤0.01%
58
CBAY
1272
DELISTED
Cymabay Therapeutics
CBAY
$1K ﹤0.01%
152
ICPT
1273
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1K ﹤0.01%
62
SURF
1274
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1K ﹤0.01%
77
SPPI
1275
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1K ﹤0.01%
321

Similar funds

Daiwa Securities Group's Q3 2021 Portfolio in Review

As of Q3 2021, Daiwa Securities Group held 1,371 positions worth $15.2B, up 2.5% from $14.8B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group's Q3 2021 filing shows 97 new, 870 increased, 195 reduced and 30 closed positions. Its largest new stake was Global X Cloud Computing ETF: 500,000 shares worth $14.6M. The largest sale was Equinix, an estimated $266M.

By sector, the portfolio is most concentrated in Real Estate at 56% of assets, down from 59% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q3 2021 buy was Global X Cloud Computing ETF: 500,000 shares worth $14.6M.
  • Daiwa Securities Group added most to Invitation Homes in Q3 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q3 2021 reduction was Equinix, cutting an estimated $266M.
  • Daiwa Securities Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.09M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $15.2B portfolio in Q3 2021.
  • Daiwa Securities Group opened 97 new positions and closed 30 in Q3 2021.
  • Daiwa Securities Group's portfolio value rose 2.5% quarter-over-quarter to $15.2B.

Based on Daiwa Securities Group's 13F filing for Q3 2021, filed 5 Nov 2021.